Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
J Endocrinol ; 242(2): R51-R65, 2019 08.
Artigo em Inglês | MEDLINE | ID: mdl-31189134

RESUMO

Puberty is driven by sophisticated neuroendocrine networks that timely activate the brain centers governing the reproductive axis. The timing of puberty is genetically determined; yet, puberty is also sensitive to numerous internal and external cues, among which metabolic/nutritional signals are especially prominent. Compelling epidemiological evidence suggests that alterations of the age of puberty are becoming more frequent; the underlying mechanisms remain largely unknown, but the escalating prevalence of obesity and other metabolic/feeding disorders is possibly a major contributing factor. This phenomenon may have clinical implications, since alterations in pubertal timing have been associated to adverse health outcomes, including higher risk of earlier all-cause mortality. This urges for a better understanding of the neurohormonal basis of normal puberty and its deviations. Compelling evidence has recently documented the master role of hypothalamic neurons producing kisspeptins, encoded by Kiss1, in the neuroendocrine pathways controlling puberty. Kiss1 neurons seemingly participate in transmitting the regulatory actions of metabolic cues on pubertal maturation. Key cellular metabolic sensors, as the mammalian target of rapamycin (mTOR), AMP-activated protein kinase (AMPK) and the fuel-sensing deacetylase, SIRT1, have been recently shown to participate also in the metabolic modulation of puberty. Recently, we have documented that AMPK and SIRT1 operate as major molecular effectors for the metabolic control of Kiss1 neurons and, thereby, puberty onset. Alterations of these molecular pathways may contribute to the perturbation of pubertal timing linked to conditions of metabolic stress in humans, such as subnutrition or obesity and might become druggable targets for better management of pubertal disorders.


Assuntos
Metabolismo Energético/fisiologia , Desnutrição/fisiopatologia , Obesidade/fisiopatologia , Puberdade/fisiologia , Maturidade Sexual/fisiologia , Animais , Feminino , Humanos , Hipotálamo/fisiologia , Sistemas Neurossecretores/fisiologia
2.
Nat Commun ; 9(1): 4194, 2018 10 10.
Artigo em Inglês | MEDLINE | ID: mdl-30305620

RESUMO

Puberty is regulated by epigenetic mechanisms and is highly sensitive to metabolic and nutritional cues. However, the epigenetic pathways mediating the effects of nutrition and obesity on pubertal timing are unknown. Here, we identify Sirtuin 1 (SIRT1), a fuel-sensing deacetylase, as a molecule that restrains female puberty via epigenetic repression of the puberty-activating gene, Kiss1. SIRT1 is expressed in hypothalamic Kiss1 neurons and suppresses Kiss1 expression. SIRT1 interacts with the Polycomb silencing complex to decrease Kiss1 promoter activity. As puberty approaches, SIRT1 is evicted from the Kiss1 promoter facilitating a repressive-to-permissive switch in chromatin landscape. Early-onset overnutrition accelerates these changes, enhances Kiss1 expression and advances puberty. In contrast, undernutrition raises SIRT1 levels, protracts Kiss1 repression and delays puberty. This delay is mimicked by central pharmacological activation of SIRT1 or SIRT1 overexpression, achieved via transgenesis or virogenetic targeting to the ARC. Our results identify SIRT1-mediated inhibition of Kiss1 as key epigenetic mechanism by which nutritional cues and obesity influence mammalian puberty.


Assuntos
Epigênese Genética , Kisspeptinas/genética , Fenômenos Fisiológicos da Nutrição , Obesidade/metabolismo , Maturidade Sexual , Sirtuína 1/metabolismo , Animais , Núcleo Arqueado do Hipotálamo/metabolismo , Cromatina/metabolismo , Feminino , Histonas/metabolismo , Hipotálamo/metabolismo , Kisspeptinas/metabolismo , Camundongos Transgênicos , Modelos Biológicos , Neurônios/metabolismo , Estado Nutricional , Complexo Repressor Polycomb 2/metabolismo , Regiões Promotoras Genéticas , Ratos , Ratos Wistar , Fatores de Tempo
3.
J Neuroendocrinol ; 22(6): 543-56, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20298456

RESUMO

Current evidence demonstrates that the stomach-derived hormone ghrelin, a potent growth hormone (GH) secretagogue, promotes feeding through a mechanism involving the short-term activation of hypothalamic AMP-activated protein kinase (AMPK), which in turn results in decreased hypothalamic levels of malonyl-CoA and increased carnitine palmitoyltransferase 1 (CPT1) activity. Despite this evidence, no data have been reported about the effect of chronic, central ghrelin administration on hypothalamic fatty acid metabolism. In the present study, we examined the differences in hypothalamic fatty acid metabolism in the presence and absence of GH, by using a model for the study of GH-deficiency, namely the spontaneous dwarf rat and the effect of long-term central ghrelin treatment and starvation on hypothalamic fatty acid metabolism in this animal model. Our data showed that GH-deficiency induces reductions in both de novo lipogenesis and beta-oxidation pathways in the hypothalamus. Thus, dwarf rats display reductions in fatty acid synthase (FAS) mRNA expression both in the ventromedial nucleus of the hypothalamus (VMH) and whole hypothalamus, as well as in FAS protein and activity. CPT1 activity was also reduced. In addition, in the present study, we show that chronic ghrelin treatment does not promote AMPK-induced changes in the overall fluxes of hypothalamic fatty acid metabolism in normal rats and that this effect is independent of GH status. By contrast, we demonstrated that both chronic ghrelin and fasting decreased FAS mRNA expression in the VMH of normal rats but not dwarf rats, suggesting GH status dependency. Overall, these results suggest that ghrelin plays a dual time-dependent role in modulating hypothalamic lipid metabolism. Understanding the molecular mechanism underlying the interplay between GH and ghrelin on hypothalamic lipid metabolism will allow new strategies for the design and development of suitable drugs for the treatment of GH-deficiency, obesity and its comorbidities.


Assuntos
Proteínas Quinases Ativadas por AMP/metabolismo , Grelina/fisiologia , Hormônio do Crescimento/deficiência , Hipotálamo/metabolismo , Metabolismo dos Lipídeos , Animais , Western Blotting , Hibridização In Situ , Masculino , Reação em Cadeia da Polimerase , Ratos , Ratos Endogâmicos Lew
4.
Int J Obes (Lond) ; 31(2): 371-7, 2007 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-16801924

RESUMO

OBJECTIVE: To study the effect of perinatal programming and overfeeding on the hypothalamic control mechanisms of food intake in adult rats. DESIGN: Neonatal programming effects on body weight, food intake, central and peripheral leptin levels, hypothalamic neuropeptides, leptin receptors and central leptin responsiveness in adult rats. MEASUREMENTS: Plasma and cerebrospinal fluid (CSF) leptin levels were analyzed using radioimmunoassay. Neuropeptide mRNA levels were analyzed using in situ hybridization. Leptin receptor mRNA levels were analyzed using reverse transcriptase-polymerase chain reaction. RESULTS: Perinatally overfed rats growing up in small litters (SL) maintain their obese and hyperleptinemic phenotype in adulthood. However, leptin levels in CSF are abnormally low considering the plasmatic hyperleptinemia. In contrast to the already reported changes in perinatally overfed juvenile rats, perinatally overfed adult rats did not show any alteration in the expression of leptin receptor isoforms and evaluated neuropeptides. Moreover, SL adult rats showed a normal sensitivity regarding the inhibitory effect of intracerebroventricular leptin administration on food intake. CONCLUSION: Perinatal overfeeding does not induce alterations in either the anorectic response to central leptin administration or expression of leptin receptors and neuropeptides in adulthood. The leptin resistance to peripheral leptin in SL adult rats may be related to impaired leptin transport across the blood-brain barrier.


Assuntos
Ingestão de Alimentos/fisiologia , Leptina/sangue , Animais , Barreira Hematoencefálica/fisiologia , Tamanho Corporal/fisiologia , Peso Corporal/fisiologia , Ingestão de Alimentos/efeitos dos fármacos , Feminino , Regulação da Expressão Gênica , Hipotálamo/metabolismo , Hibridização In Situ , Leptina/líquido cefalorraquidiano , Leptina/farmacologia , Neuropeptídeos/biossíntese , Neuropeptídeos/genética , Obesidade/sangue , Obesidade/líquido cefalorraquidiano , Obesidade/fisiopatologia , Gravidez , RNA Mensageiro/genética , Ratos , Ratos Sprague-Dawley , Receptores de Superfície Celular/biossíntese , Receptores de Superfície Celular/genética , Receptores para Leptina , Reação em Cadeia da Polimerase Via Transcriptase Reversa/métodos
5.
Endocrinology ; 147(5): 2374-82, 2006 May.
Artigo em Inglês | MEDLINE | ID: mdl-16455774

RESUMO

Ghrelin, the endogenous ligand of GH secretagogue receptor type 1a, has emerged as pleiotropic modulator of diverse biological functions, including energy homeostasis and, recently, reproduction. Although inhibitory actions of ghrelin on LH secretion and puberty onset have been reported previously, the receptor mechanisms mediating these actions, and the potential gonadotropic effects of the unacylated isoform of ghrelin (UAG), remain unclear. In this work, the effects of single and repeated administration of ghrelin or UAG on LH secretion were compared in pubertal and adult male rats. In addition, the effects of ghrelin were assessed in models of transient or persistent hypergonadotropism. Daily injection of ghrelin or UAG throughout puberty similarly decreased LH levels and partially delayed balanopreputial separation. Likewise, chronic infusion of ghrelin or UAG to adult males resulted in significant decreases in circulating LH and FSH concentrations. Moreover, acute injection of ghrelin induced a transient reduction in LH levels in freely moving males, an effect that was fully mimicked by administration of UAG. Yet in contrast to ghrelin, UAG failed to modify GH secretion. Finally, injection of ghrelin moderately, but significantly, reduced the duration of LH secretory responses to the potent gonadotropin secretagogue kisspeptin-10, whereas ghrelin infusion in a model of chronic elevation of serum gonadotropin levels (the transgenic growth retarded male rat) evoked a significant reduction of LH concentrations. Altogether our present results further substantiate the inhibitory effect of ghrelin on basal and stimulated LH secretion in a wide array of experimental conditions. Moreover, our data are the first to demonstrate the ability of UAG, originally considered an inert form of the molecule, to mimic the actions of acylated ghrelin on LH release. These observations reinforce the contention that ghrelin, as putative signal for energy insufficiency, may operate as negative modifier of male puberty and LH secretion, an effect that might be, at least partially, conducted through a GH secretagogue receptor type 1a-independent mechanism.


Assuntos
Hormônio Luteinizante/metabolismo , Hormônios Peptídicos/farmacologia , Animais , Hormônio Foliculoestimulante/metabolismo , Grelina , Gonadotropinas/metabolismo , Hormônio do Crescimento/metabolismo , Homeostase , Hipotálamo/metabolismo , Kisspeptinas , Ligantes , Masculino , Hormônios Peptídicos/metabolismo , Proteínas/metabolismo , Radioimunoensaio , Ratos , Ratos Sprague-Dawley , Ratos Wistar , Fatores de Tempo
6.
Rev Esp Quimioter ; 19(4): 342-8, 2006 Dec.
Artigo em Espanhol | MEDLINE | ID: mdl-17235403

RESUMO

The aim of this study was to determine if there were differences in the antibiotic consumption among the pediatric population of the eleven Primary Health Care centers in the Community of Castilla Leon during the years 2001-2005 and to analyze the possible causes. Data of non-hospital antibiotic consumption in the pediatric population provided the amount of antibiotics billed in the Health Service of the area of Castilla and Leon (central region of Spain). The data was analyzed according to the Anatomic Therapeutic Chemical Classification System (ATC) and expressed as defined daily doses per 1000 inhabitants per day (DID). There were statistically significant differences in the use of antibiotics, varying 8.3 DID between the area with the highest rate (24.86 DID in Leon) and the area with the lowest rate (16.56 DID in Soria). The temporal fluctuations were great and varied especially in Segovia. The pattern of prescribing also varied. The use of penicillin in combination with beta-lacatamase inhibitors varied by a factor of almost three times between Burgos and Segovia. Segovia showed the best management in antibiotic prescriptions with data showing low consumption based on prescribing recommendations. Data from Soria showed low consumption but patterns of misuse in regard to protocols and prescribing. There was wide quantitative and qualitative variability of antibiotic use among the primary health care centers in the region of Castilla and Leon. More detailed studies by age groups, welfare pressure and indication are needed to better understand the determinants of antibiotic use in children.


Assuntos
Antibacterianos/uso terapêutico , Infecções Bacterianas/tratamento farmacológico , Prescrições de Medicamentos/estatística & dados numéricos , Padrões de Prática Médica/estatística & dados numéricos , Adolescente , Antibacterianos/administração & dosagem , Antibacterianos/classificação , Infecções Bacterianas/epidemiologia , Criança , Pré-Escolar , Serviços de Informação sobre Medicamentos/estatística & dados numéricos , Uso de Medicamentos/estatística & dados numéricos , Feminino , Humanos , Lactente , Masculino , Programas Nacionais de Saúde/estatística & dados numéricos , Pediatria/estatística & dados numéricos , Atenção Primária à Saúde/estatística & dados numéricos , Estudos Retrospectivos , Espanha/epidemiologia , Fatores de Tempo
7.
Endocrinology ; 146(9): 3917-25, 2005 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-15932928

RESUMO

Activation of the gonadotropic axis critically depends on sufficient body energy stores, and conditions of negative energy balance result in lack of puberty onset and reproductive failure. Recently, KiSS-1 gene-derived kisspeptin, signaling through the G protein-coupled receptor 54 (GPR54), has been proven as a pivotal regulator in the control of gonadotropin secretion and puberty. However, the impact of body energy status upon hypothalamic expression and function of this system remains unexplored. In this work, we evaluated the expression of KiSS-1 and GPR54 genes at the hypothalamus as well as the ability of kisspeptin-10 to elicit GnRH and LH secretion in prepubertal rats under short-term fasting. In addition, we monitored the actions of kisspeptin on food intake and the effects of its chronic administration upon puberty onset in undernutrition. Food deprivation induced a concomitant decrease in hypothalamic KiSS-1 and increase in GPR54 mRNA levels in prepubertal rats. In addition, LH responses to kisspeptin in vivo were enhanced, and its GnRH secretagogue action in vitro was sensitized, under fasting conditions. Central kisspeptin administration failed to change food intake patterns in animals fed ad libitum or after a 12-h fast. However, chronic treatment with kisspeptin was able to restore vaginal opening (in approximately 60%) and to elicit gonadotropin and estrogen responses in a model of undernutrition. In summary, our data are the first to show an interaction between energy status and the hypothalamic KiSS-1 system, which may constitute a target for disruption (and eventual therapeutic intervention) of pubertal development in conditions of negative energy balance.


Assuntos
Hipotálamo/fisiologia , Desnutrição/fisiopatologia , Proteínas/genética , Proteínas/metabolismo , Animais , Ingestão de Alimentos/fisiologia , Feminino , Privação de Alimentos/fisiologia , Expressão Gênica , Kisspeptinas , Masculino , Ratos , Ratos Wistar , Receptores Acoplados a Proteínas G , Receptores de Kisspeptina-1 , Receptores de Neuropeptídeos/genética , Receptores de Neuropeptídeos/metabolismo , Índice de Gravidade de Doença , Maturidade Sexual/fisiologia
8.
Nutr Hosp ; 17(3): 159-67, 2002.
Artigo em Espanhol | MEDLINE | ID: mdl-12149816

RESUMO

GOAL: To identify the current status of out-patient enteral nutrition among elderly patients in Galicia: indications, access routes, forms of administration, types of diet, complications, disability status. Assessment of nutritional status and concomitant pharmacological treatment. METHODS: Prospective, observational, multi-centric study lasting for one month. Data capture by means of a questionnaire regarding: age, sex, diagnosed pathology leading to nutritional analysis, disability status, current nutritional status, type of diet, months under treatment with NEA (out-patient enteral nutrition in its Spanish acronym), form of administration, complications, concomitant medication. The statistical methodology included a descriptive analysis and a study of the correlations between the different variables. For the comparison of both groups, Student's t test or Mann-Whitney's U test was used for quantitative variables and chi-squared, Yate's correction or Fisher's exact test was used for qualitative variables. RESULTS: 469 patients were studied, corresponding to 13 publicly-funded centres. Age: 81.15 years (95% CI 80.8-82.3), women (70.6%). DIAGNOSIS: neurological disorders (46.1%), cerebrovascular accidents (27.5%), neoplasia (12.4%) and others (14.1%). 45.2% presented a bedbound disability status and 53.5% presented communication difficulties. Standard diet was the most common (39.4%). DURATION OF THE NUTRITION: > 1 year in 36.7% of cases, between 6 months and 1 year for 21.3%, between 3 and 6 months for 10.9% and < 3 months in 13.7% of cases. Nasogastric tube was the route for administration in 55.2%. Patients with nutrition treatment lasting over 1 year presented a significantly lower rate of malnutrition (p < 0.0001). Neurological patients and those with communication difficulties had a lower prevalence of malnutrition (p < 0.0001), as did those with a greater degree of disability (p < 0.01). Undernourished patients presented a greater prevalence of bedsores (49.1% versus 25.8%, p < 0.0001). The mean number of prescribed medicines was 3.27 +/- 2.41, with 64% of them being administered through the nasogastric tube. The most frequent interaction was digoxin-fibre (29.6%) and incorrect administration was observed with omeprazol and medication to combat Parkinson's disease.


Assuntos
Inquéritos Nutricionais , Pacientes Ambulatoriais , Idoso , Idoso de 80 Anos ou mais , Transtornos Cerebrovasculares/epidemiologia , Transtornos da Comunicação/epidemiologia , Comorbidade , Grupos Diagnósticos Relacionados , Pessoas com Deficiência , Tratamento Farmacológico/estatística & dados numéricos , Nutrição Enteral/estatística & dados numéricos , Feminino , Alimentos Formulados , Humanos , Masculino , Neoplasias/epidemiologia , Doenças do Sistema Nervoso/epidemiologia , Distúrbios Nutricionais/epidemiologia , Fenômenos Fisiológicos da Nutrição , Ambulatório Hospitalar/estatística & dados numéricos , Estudos Prospectivos , Espanha/epidemiologia , Inquéritos e Questionários
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA